What We're Reading
Industry reads hand-picked by our editors
Feb 13, 2026
-
Reuters
China biotech licensing boom to hit record in 2026 as pipeline swells
-
Quanta Magazine
Fed on Reams of Cell Data, AI Maps New Neighborhoods in the Brain
-
The New York Times
Health Advice From A.I. Chatbots Is Frequently Wrong, Study Shows
-
National Geographic
These drugs could be a game changer for end-of-life care
Feb 12, 2026
-
The Wall Street Journal
Why the FDA Blocked Moderna’s New Flu Shot
-
The Atlantic
A Tragedy of Early COVID Has Finally Been Explained
-
Fierce Biotech
‘The only thing that saves us is data’: Allogeneic CAR-T biotechs fight for relevance as industry moves on
Feb 11, 2026
Feb 10, 2026
Feb 09, 2026
Feb 06, 2026
-
The New York Times
Kennedy Makes Unfounded Claim That Keto Diet Can ‘Cure’ Schizophrenia
-
NPR
GLP-1 obesity drugs can complicate life for people with disordered eating
-
STAT
Vertex’s CRISPR treatment for sickle cell disease hits unexpected roadblock
-
The Financial Times
Labels on statins overstate side effects, study finds
